Literature DB >> 16013082

Pharmacokinetic/pharmacodynamic differentiation of pancreatic responsiveness in obese and lean children.

N Gupta1, R P Hoffman, P Veng-Pedersen.   

Abstract

OBJECTIVE: To determine the feasibility of differentiating the glucose-stimulated plasma insulin response between lean and obese children using a new PK/PD model that specifically considers the insulin-glucose physiology of beta cells.
METHODS: Twenty four blood samples obtained after an intravenous bolus administration of glucose (250 mg/kg) were analysed for glucose and insulin concentrations in a group of six obese children, age 10.8 +/- 12.9 years (mean +/- CV%); BMI 26.7 +/- 27.8 kg/m(2), and six lean children, age 10.3 +/- 10.5, BMI 15.7 +/- 10.8.
RESULTS: A PK/PD analysis of insulin concentration was performed and significant differences (p < 0.05) were determined from the parameters of our model in first and second phase insulin secretion between obese vs lean subjects. The estimated proinsulin formation rate constant was significantly higher in the obese group compared with the lean group (1.60 +/- 43.1 vs 0.378 +/- 40.9 min(-1)). The half-life of insulin in plasma was calculated to be 6.36 +/- 39.9 min for the obese group and 6.84 +/- 30.1 min for the lean group. The new model showed good agreement with data for both the obese group (r = 0.962 +/- 4.56) and for the lean group (r = 0.980 +/- 1.93).
CONCLUSION: The proposed model is able to differentiate between lean and obese prepubertal children via specific kinetic parameters relating to beta-cell function. Copyright 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16013082     DOI: 10.1002/bdd.461

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  4 in total

1.  Uptake, efflux, and mass transfer coefficient of fluorescent PAMAM dendrimers into pancreatic cancer cells.

Authors:  Armin W Opitz; Kirk J Czymmek; Eric Wickstrom; Norman J Wagner
Journal:  Biochim Biophys Acta       Date:  2012-09-26

2.  Population analysis of ethnicity and first-phase insulin release.

Authors:  Lanyi Xie; Robert P Hoffman; Peter Veng-Pedersen
Journal:  Diabetes Res Clin Pract       Date:  2010-05-31       Impact factor: 5.602

Review 3.  Pharmacokinetic/pharmacodynamic modelling in diabetes mellitus.

Authors:  Cornelia B Landersdorfer; William J Jusko
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

4.  Analysis of PK/PD risk factors for development of type 2 diabetes in high risk population using Bayesian analysis of glucose-insulin kinetics.

Authors:  Chih-Wei Lin; Peter Veng-Pedersen
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-09-16       Impact factor: 2.745

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.